Life Tech to Redeem Convertible Senior Notes | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies said on Friday it intends to redeem all of the outstanding 1.5 percent convertible senior notes due 2024.

The company intends to redeem the all of the notes on Feb. 15, and said that as of Dec. 31, 2011, $450 million in aggregate principal amount of the notes were outstanding. The notes are convertible prior to Feb. 14, 5 p.m. EST at a rate of 19.603 shares of common stock for each $1,000 principal amount of the notes surrendered.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

Widespread genome sequencing might not be justified just yet, USA Today reports.